Starting DTC telehealth is a business design problem
Most founders start with the visible parts:
- a landing page
- a treatment category
- a provider relationship
- a payment flow
- a pharmacy partner
- a marketing channel
Those pieces matter.
But they are not the business.
A DTC telehealth business is the full patient journey from first click to ongoing care.
That means the launch plan has to answer:
- who the program is for
- how patients are qualified
- who reviews them
- what happens if they are not a fit
- how payment works
- how prescriptions, labs, or referrals are handled
- where patients see status
- how support escalates questions
- what happens after the first order, visit, refill, or renewal
If those answers are unclear, the business may still launch.
It just launches with support debt built in.
Budget before you sequence: the line items, from entities to ads, are in how much it costs to start a telehealth business.
Updated September 22, 2026: added step 5 (payment processing: Stripe's restricted category, Visa's 1.5% VAMP threshold, reserves) and step 10 (LegitScript: $975 plus $2,150 a year, four to eleven weeks), plus a post-compounding note on GLP-1 pharmacy planning after the Fifth Circuit's August 27 ruling.
1. Choose a program you can actually operate
Do not choose the first program only by demand.
Choose it by demand plus operational fit.
Common DTC telehealth categories include:
- GLP-1 and metabolic care
- hair loss
- sexual health
- menopause and women's health
- longevity and peptides
- dermatology
- mental health
- general wellness programs
Compare each category by:
| Dimension | What to ask |
|---|---|
| Demand | Are patients already searching and ready to pay? |
| Clinical complexity | How much review, follow-up, or escalation is needed? |
| Pharmacy dependency | Does the program rely on reliable fulfillment? |
| Lab dependency | Are labs optional, required, or follow-up only? |
| Repeat care | Is there a natural refill, renewal, or follow-up cadence? |
| Compliance sensitivity | Are claims, prescribing, or product sourcing especially risky? |
| Brand fit | Does this fit the audience you can reach? |
Related reading: Telehealth Specialty Expansion: How to Decide the Next Program After GLP-1, Hair Loss, or Sexual Health.
2. Decide the provider model early
Your provider model changes the whole operating plan.
You may use:
- your own clinicians
- an external provider network
- a hybrid model
- specialty reviewers for escalation
The decision affects:
- state coverage
- review speed
- clinical quality
- documentation
- support escalation
- protocol updates
- patient trust
- cost per completed start
Do not treat the provider model as a staffing detail.
It shapes the product.
Whichever model you pick, the professional entity needs a physician owner or medical director, and a nurse practitioner outside the full-practice-authority states needs a collaborating physician ($500 to $1,000 a month is what NPs report). Sourcing and pricing are in the medical director hiring guide.
Related reading: Provider Network vs. Your Own Clinicians: How DTC Telehealth Brands Should Choose.
3. Build intake around routing, not just conversion
The intake should be easy to complete.
But it also has to collect enough information for safe routing and provider review.
A strong first intake usually captures:
- identity and contact details
- state
- basic eligibility signals
- medical history relevant to the program
- medication history
- allergy and contraindication signals
- patient goals
- consent
- photos, documents, or labs when appropriate
- payment-path preference where relevant
The goal is not to make the form longer.
The goal is to make every question earn its place.
4. Define the payment model before checkout
DTC telehealth businesses usually choose one or more payment paths:
- one-time consult
- subscription
- membership
- medication-included bundle
- consult plus pharmacy payment
- insurance-supported path
- hybrid self-pay and insurance
- installment or financing option
Each model creates different patient expectations.
Before launch, define:
- what the first payment covers
- what is recurring
- whether medication is included
- whether labs are included
- what happens if the provider does not approve treatment
- how refunds work
- how cancellations work
- how failed renewals are handled
If pricing is unclear, the support team will pay for it later.
5. Get payment processing approved before you need it
Telehealth is a restricted category at the processor you were planning to use. Stripe's restricted-businesses page, updated May 13, 2026, lists "Telemedicine and telehealth services", "Online pharmacies, including SaaS platforms" and "Card-not-present prescription-only products" as businesses that need approval, and approval can be withdrawn.
Before launch:
- apply under the MSO with the PC named; underwriting will ask for the medical director, the pharmacy, the refund policy, and the checkout flow
- plan for a rolling reserve of 5% to 10% of revenue in the first months; it is your cash, held
- keep disputes under Visa's VAMP threshold: 1.5% of settled card-not-present transactions (fraud plus disputes) since April 1, 2026, with an $8 fee per disputed transaction above it
- charge only after clinical approval, send renewal notices, and make cancellation one click
The underwriting details are in passing payment processor review.
6. Pick the pharmacy and fulfillment model
If the program involves prescriptions, pharmacy is part of the product experience.
Decide whether the model uses:
- partner pharmacy
- patient-selected pharmacy
- local pickup
- home delivery
- manufacturer or direct-access channel
- compounded pharmacy where appropriate and compliant
Post-compounding note, September 2026: the Fifth Circuit affirmed FDA on August 27 in Outsourcing Facilities Association v. FDA (Nos. 25-10600 and 25-10758), so the shortage-list fight over compounded tirzepatide and semaglutide is effectively over, and FDA's order removing semaglutide, tirzepatide and liraglutide from the 503B bulks list (proposed April 30) is still pending. Plan a GLP-1 program around branded supply (the Wegovy pill at $149 to $299, Foundayo at $149 to $349, Zepbound vials at $299 to $449) and treat compounded as patient-specific 503A only.
Before launch, validate:
- state coverage
- prescription routing
- fill timing
- patient-facing status updates
- exception handling
- refill process
- support ownership
- pharmacy contact path
The patient does not separate "your brand" from "the pharmacy experience."
If the pharmacy workflow is confusing, the brand feels confusing.
7. Give patients a portal before support gets flooded
Patients need somewhere to understand what is happening.
The portal should show:
- intake status
- provider-review status
- payment or renewal status
- prescription or order status
- refill tasks
- lab instructions or results where applicable
- secure messaging
- plan or subscription information
- next step
Without that visibility, patients will ask support for every update.
8. Write the support playbook before launch
Support should not improvise the first week.
Create approved responses for:
- eligibility questions
- pricing and refunds
- provider-review timing
- pharmacy status
- side-effect routing
- lab instructions
- insurance or self-pay questions
- cancellation requests
- urgent escalation
- "not a fit" outcomes
Support should also know which questions are administrative and which require clinical escalation.
That boundary protects patients and the team.
9. Decide what you will not claim
DTC telehealth marketing needs discipline.
Before paid traffic starts, define claim rules:
- no guaranteed approval
- no guaranteed outcomes
- no unsupported before-and-after claims
- no vague "FDA-approved alternative" language
- no implying compounded products are the same as approved products (and, after the Fifth Circuit's August 27, 2026 ruling, no marketing compounded GLP-1 copies as a shortage alternative)
- no diagnosis by quiz
- no clinical promises support cannot back up
This is especially important in GLP-1, peptides, hormones, sexual health, and longevity.
The strongest landing pages are clear, not loud.
Related reading: Trust Signals on Telehealth Landing Pages: What Helps Conversion Without Sounding Like Hype.
10. Get LegitScript certified before you buy ads
Google, Microsoft, Meta and TikTok will not run a prescription telehealth campaign without LegitScript certification, and it is the step most founders discover after the creative is ready.
- fee: $975 per website, nonrefundable, plus $2,150 a year per website
- expedite: optional $2,500; review starts within two business days
- timeline doing it yourself: founders on r/telehealth reported four to eleven weeks (threads of September 13 and 21, 2026)
- what it reviews: the storefront, claims, prescriber and pharmacy disclosures, the privacy policy, and any compounded products, the biggest source of friction
File it the week the storefront copy is final, not the week the ads are. Karpa Health bundles the expedite at every tier and Cuvo on its Grow tier; ask your platform where it sits.
11. Launch with the right metrics
Do not measure launch only by leads.
Measure:
- landing-page conversion
- intake start rate
- intake completion rate
- qualified submission rate
- provider-review time
- approval or next-step rate
- checkout completion
- first-fill or first-appointment completion
- refund requests
- support tickets per 100 patients
- first renewal
- month-two retention
If lead volume looks good but provider review, fulfillment, support, or refunds are breaking, the business is not healthy yet.
Related reading: Subscriber Growth vs. Patient Quality: The DTC Telehealth Metrics That Actually Matter in 2026.
Final checklist before accepting patients
Before launch, make sure you have:
- a clearly defined first program
- provider model and state coverage
- intake and consent flow
- provider-review workflow
- payment model
- refund and cancellation policy
- pharmacy or fulfillment plan
- portal status visibility
- support playbook
- escalation rules
- claim and marketing review
- launch dashboard
Where a platform fits: steps 3, 4, 6, 7 and 11 are what a white-label platform ships as one system. Turbopills, which we build, runs the storefront, conditional intake, state-aware provider routing, billing that starts after clinical approval on your own gateway accounts, pharmacy routing and the branded portal, and launches in weeks; we are in private beta and quote per program, so verify those steps in a demo rather than on this page. Steps 1, 2, 5, 9 and 10 stay yours: the program, the professional entity and medical director, the processor account, the claims, and the LegitScript file.
FAQ
How much does it cost to start a telehealth business? On a white-label platform, about $20,000 to $45,000 for a single state before revenue and $60,000 to $120,000 for ten states, with the ad budget the largest line; self-assembling the stack adds $60,000 to $250,000. The full budget is in how much it costs to start a telehealth business.
Do I need LegitScript to start a telehealth business? Not to see patients, but yes to advertise: Google, Microsoft, Meta and TikTok require it for prescription telehealth campaigns. Budget $975 to apply plus $2,150 a year per website, $2,500 more to expedite, and four to eleven weeks if you file it yourself.
Can I use Stripe for a telehealth business? Yes, with approval. Stripe lists telemedicine, online pharmacies and card-not-present prescription products as restricted businesses (page updated May 13, 2026), so apply early, expect a rolling reserve of 5% to 10% at first, and keep disputes under Visa's 1.5% VAMP threshold.
Do I need a medical license to start a telehealth business? No. A non-clinician owns the management company that holds the brand, technology and operations; a licensed physician owns the professional corporation that delivers care; a management agreement connects them. The structure is in the MSO and friendly-PC model.